These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6299755)

  • 1. Solubilization and assay of [3H]imipramine binding sites from human platelets.
    Davis A; Morris J; Tang SW
    Eur J Pharmacol; 1983 Jan; 86(3-4):353-9. PubMed ID: 6299755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization and partial purification of the high affinity [3H] imipramine binding site from human platelets.
    Rehavi M; Skolnick P; Paul SM
    FEBS Lett; 1982 Dec; 150(2):514-8. PubMed ID: 6297983
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature-sensitive conformational changes in membrane-bound and solubilized [3H]imipramine binding sites.
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1983 Apr; 88(4):407-10. PubMed ID: 6861879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human platelets possess multiple [3H]imipramine binding sites.
    Ieni JR; Zukin SR; Van Praag HM
    Eur J Pharmacol; 1984 Nov; 106(3):669-72. PubMed ID: 6097465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]-imipramine binding sites in fawn-hooded rats.
    Murray TF; DeBarrows BR; Prieur DJ; Meyers KM
    Neuropharmacology; 1983 Jun; 22(6):781-4. PubMed ID: 6310435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine.
    O'Riordan C; Phillips OM; Williams DC
    J Neurochem; 1990 Apr; 54(4):1275-80. PubMed ID: 2313287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-methoxytryptoline and close analogs as candidates for the endogenous ligand of the 3H-imipramine recognition site.
    Langer SZ; Lee CR; Schoemaker H; Segonzac A; Esnaud H
    Prog Clin Biol Res; 1985; 192():441-55. PubMed ID: 3001765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-sensitive reversible loss of [3H]imipramine binding sites: evidence suggesting different conformational states.
    Dumbrille-Ross A; Morris J; Davis A; Tang SW
    Eur J Pharmacol; 1983 Aug; 91(4):383-9. PubMed ID: 6311587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.
    Kamal LA; Raisman R; Meyer P; Langer SZ
    Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
    Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
    Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-imipramine binding in platelets: influence of varying proportions of intact platelets in membrane preparations on binding.
    Friedl W; Propping P; Weck B
    Psychopharmacology (Berl); 1983; 80(1):96-9. PubMed ID: 6306712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the relationship between the uptake system for 5-hydroxytryptamine and the high-affinity [3H]imipramine binding site--I. Inhibition by drugs.
    Wood MD; Broadhurst AM; Wyllie MG
    Neuropharmacology; 1986 May; 25(5):519-25. PubMed ID: 3016589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [3H]imipramine and [3H]desipramine as biochemical tools for studies in depression.
    Langer SZ; Raisman R
    Neuropharmacology; 1983 Mar; 22(3 Spec No):407-13. PubMed ID: 6304558
    [No Abstract]   [Full Text] [Related]  

  • 16. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of [3H]Ro 11-2465. Possible identification of a subclass of [3H]imipramine binding sites.
    Dumbrille-Ross A; Tang SW
    Mol Pharmacol; 1983 May; 23(3):607-13. PubMed ID: 6306430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between sodium-dependent and desipramine-defined [3H]imipramine binding in intact human platelets.
    Hrdina PD
    Biol Psychiatry; 1989 Mar; 25(5):576-84. PubMed ID: 2537664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilization and characterization of [3H]imipramine and [3H]paroxetine binding sites from calf striatum.
    Rotondo A; Giannaccini G; Quattrone C; Marazziti D; Martini C; Cassano GB; Lucacchini A
    Neurochem Res; 1994 Oct; 19(10):1295-300. PubMed ID: 7891847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High affinity 3H-imipramine binding in human platelets: age and sex effects.
    Baron M; Kowalik S; Barkai A; Gruen R
    Neuropsychobiology; 1984; 11(3):178-80. PubMed ID: 6089031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.